glp-1 and eating disorder obesity drugs disorders are not well understood yet : NPR GLP-1 weight-loss drugs may also

Comparative efficacy and safety of antidiabetic drug regimens added to stable and inadequate metformin and thiazolidinedione therapy in type 2 diabetes

Learn more about our editorial process

These injections are usually prescribed to adults living with obesity, who have a body mass index (BMI) over 30, or over 27 if they have other weight-related health issues such as high blood pressure or prediabetes

Key Background Adverse side effects may also be causing a decline in GLP-1 use among people with type 2 diabetes

As consumer demand for GLP-1 therapies continues to surge, practices that can offer multiple delivery options will be better positioned to meet patients where they are